School of Psychology, University of Ottawa, Ottawa, Ontario, Canada.
PLoS One. 2013 Apr 18;8(4):e61586. doi: 10.1371/journal.pone.0061586. Print 2013.
Hematopoietic Stem cell Transplantation (HSCT) can negatively impact the psychosocial well-being of the patient. Social support is a complex term that has been variably used to encompass perceived and objective support, including caregiver presence. Social support has been associated with superior psychosocial outcomes; however the influence of social support on HSCT survival remains unclear. We sought to summarize the literature on the influence of social support on HSCT survival.
MEDLINE, EMBASE, COCHRANE, CINAHL, AND PSYCINFO WERE SEARCHED USING THE FOLLOWING SEARCH CATEGORIES/CONCEPTS: 1) HSCT, 2) Social support, 3) Caregiver, 4) Survival, and 5) Treatment outcomes.
We identified 6 relevant studies: 4 publications, 1 dissertation, and 1 abstract. Three studies were retrospective and 3, prospective. Sample size ranged between 92-272 with a mean/median patient age between 30-55 yrs. The duration of follow-up ranged between 13.3-48 months. Social support was measured inconsistently: 2 by retrospective investigator assessment, 2 as patients' perceived support, 1 as caregiver presence, and 1 included caregiver presence and retrospective investigator assessment. The 4 published studies and 1 abstract demonstrate an association between better social support and survival. However, the unpublished dissertation, with the largest sample size found no association.
There is a paucity of evidence examining social support with HSCT survival. Available studies are older, with the most recent publication in 2005. A heterogeneous group of HSCT patients were studied with variable follow-up times. Further, covariates were variably considered in HSCT survival analyses and we suggest that there may be publication bias, given the negative unpublished study with the largest sample size. Prospective studies using validated scales are necessary to better assess the influence of social support on HSCT mortality. Given the potential for improved HSCT survival with better social support, HSCT centres should routinely provide HSCT recipients and their caregivers with enhanced psychosocial services.
造血干细胞移植(HSCT)会对患者的社会心理健康产生负面影响。社会支持是一个复杂的术语,其含义因研究而异,包括照顾者的存在。社会支持与更好的社会心理结果相关;然而,社会支持对 HSCT 生存的影响尚不清楚。我们旨在总结关于社会支持对 HSCT 生存影响的文献。
使用以下搜索类别/概念在 MEDLINE、EMBASE、COCHRANE、CINAHL 和 PSYCINFO 中搜索:1)HSCT、2)社会支持、3)照顾者、4)生存和 5)治疗结果。
我们确定了 6 项相关研究:4 项出版物、1 项论文和 1 项摘要。3 项研究为回顾性,3 项为前瞻性。样本量范围为 92-272,患者平均/中位数年龄为 30-55 岁。随访时间范围为 13.3-48 个月。社会支持的测量不一致:2 项由回顾性研究者评估,2 项为患者感知的支持,1 项为照顾者的存在,1 项包括照顾者的存在和回顾性研究者评估。4 项已发表的研究和 1 项摘要表明,更好的社会支持与生存相关。然而,未发表的论文,样本量最大,未发现相关性。
关于社会支持与 HSCT 生存关系的证据有限。现有研究较陈旧,最近的出版物是在 2005 年。研究了一组异质性的 HSCT 患者,随访时间不同。此外,在 HSCT 生存分析中,协变量的考虑各不相同,我们建议由于最大样本量的未发表研究为阴性,可能存在发表偏倚。需要使用经过验证的量表进行前瞻性研究,以更好地评估社会支持对 HSCT 死亡率的影响。鉴于更好的社会支持可能会提高 HSCT 的生存,HSCT 中心应常规为 HSCT 受者及其照顾者提供增强的社会心理服务。